🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Investigational Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are urged to message these profiles directly for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Vendors market the drug there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals injecting substances of uncertain source.

Several professionals stated the popularity for the experimental drug could be linked to the rising price of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, potentially leading to fines, prosecution or imprisonment.

Platform Response and Material Removal

Based on the social media company, the platform has removed problematic content and banned associated keywords and search suggestions. The organization stated it was committed to keeping the platform secure and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Research also found groups with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately displays groups with numerous of members, populated with images of weight loss, positive reviews and step-by-step guides for preparing or injecting at home.

After moments of joining one group, a vendor posted WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, medical conditions or previous experience.

Item Details and Costs

Within these groups, posts show dark colored packages with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When questioned how long a injector should last, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service stated it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they can’t verify. Even if the science behind this drug is sound, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current price rises for approved weight-loss medications such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.

Her team has previously encountered patients injured by personal administration from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject users to possibly serious health risks”.